Results 81 to 90 of about 822,055 (188)

¹⁷⁷Lutetium PSMA radioligand therapy for the treatment of metastatic castrate-resistant prostate cancer: Evidence synthesis to support a generic justification decision

open access: yes
This review was conducted in response to an application submitted by a radiologist at the Mater Misericordiae University Hospital for the generic justification of lutetium (177Lu) prostate-specific membrane antigen (PSMA) radioligand therapy for the ...
Health Information and Quality Authority (HIQA)
core  

Labelling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study.

open access: yes, 1998
Molecular biology studies have demonstrated that human peripheral blood lymphocytes express dopamine D2-like receptors belonging to the D3 and D4 receptor subtypes, whereas the characterization of these receptors using radioligand binding assay ...
AMENTA, Francesco
core   +1 more source

A Flexible, Robust Microbead-based Assay for Quantification and Normalization of Target Protein Concentrations

open access: yes, 2020
There are many methods for quantifying the concentration of a specific (target) protein in a sample, but current techniques are technically challenging or do not easily lend themselves to normalizing measured protein concentrations against the total ...
Crowley, Alexandra
core  

Development of pH-Sensitive β‑Adrenergic Receptor Antagonists. [PDF]

open access: yesACS Pharmacol Transl Sci
Braun T   +4 more
europepmc   +1 more source

Development of Novel Pegylated Imidazobenzodiazepines Targeting α5 GABAA Receptors for Anxiety: A Comparative Prodrug and Metabolite Study. [PDF]

open access: yesACS Chem Neurosci
Toriola MA   +10 more
europepmc   +1 more source

AB-MDMSBA-Not a Synthetic Cannabinoid Receptor Agonist. [PDF]

open access: yesPharmacol Res Perspect
Patel M   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy